Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Zydus Lifesciences Ltd. market cap is 643.2B.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Zydus Lifesciences Ltd. 52 week high is 668.75 as of December 07, 2023.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Zydus Lifesciences Ltd. 52 week low is 403.20 as of December 07, 2023.
Zydus Lifesciences Ltd. stock price today is 657.95.
Zydus Lifesciences Ltd. stock price yesterday was 635.45.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Zydus Lifesciences Ltd.’s P/E ratio is 22.91.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Zydus Lifesciences Ltd. P/B ratio is 3.4336.
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Zydus Lifesciences Ltd.'s EBITDA is 12.98.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Zydus Lifesciences Ltd. 50-day moving average is 607.17.
Zydus Lifesciences Ltd. has 23,026 employees.
3rd Party Ad. Not an offer or recommendation by Stocktwits. See disclosure here.